We are live on ! Find out more
LA

Lee Ainslie Maverick Capital

AUM $11.3B
1-Year Est. Return 76.6%
 

Lee Ainslie is the founder of Maverick Capital, a long/short equity firm that emerged from the Tiger Management network of investors. Maverick is known for fundamental research, sector specialization among teams, and a classic hedge fund long/short structure. Ainslie’s firm remains a reference name among so-called Tiger Cub managers.

This Fund
S&P 500
This Quarter Est. Return
+3.39%
1 Year Est. Return
+76.6%
3 Year Est. Return
+266.43%
5 Year Est. Return
+219.63%
10 Year Est. Return
+601.38%
AUM
$10.9B
AUM Growth
+$4.61B
Cap. Flow
+$4.39B
Cap. Flow %
40.45%
Top 10 Hldgs %
64.91%
Holding
930
New
269
Increased
166
Reduced
249
Closed
242

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 55.3%
2 Healthcare 12.47%
3 Technology 11.12%
4 Communication Services 7.76%
5 Financials 5.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPA icon
651
Copa Holdings
CPA
$5.88B
$45K ﹤0.01%
+558
New +$46.4K
ALLE icon
652
Allegion
ALLE
$13.8B
$44K ﹤0.01%
+351
New +$40.5K
CDLX icon
653
Cardlytics
CDLX
$25.3M
$42K ﹤0.01%
+38
New +$50.2K
ATO icon
654
Atmos Energy
ATO
$28.2B
$39K ﹤0.01%
+392
New +$35.7K
COHR icon
655
Coherent
COHR
$56.7B
$37K ﹤0.01%
535
-7,758
-94% -$637K
TTWO icon
656
Take-Two Interactive
TTWO
$44.8B
$34K ﹤0.01%
+190
New +$36K
PRAH
657
DELISTED
PRA Health Sciences, Inc.
PRAH
$34K ﹤0.01%
+224
New +$30.4K
EXAS
658
DELISTED
Exact Sciences
EXAS
$30K ﹤0.01%
+224
New +$30.7K
OMF icon
659
OneMain Financial
OMF
$7.27B
$28K ﹤0.01%
523
-1,296
-71% -$66.9K
AMGN icon
660
Amgen
AMGN
$238B
$27K ﹤0.01%
+109
New +$26K
DFS
661
DELISTED
Discover Financial Services
DFS
$27K ﹤0.01%
281
-109
-28% -$10.3K
REZI icon
662
Resideo Technologies
REZI
$3.08B
$27K ﹤0.01%
+954
New +$25.2K
KMI icon
663
Kinder Morgan
KMI
$69B
$25K ﹤0.01%
1,515
-67,660
-98% -$1.03M
MGA icon
664
Magna International
MGA
$19.5B
$25K ﹤0.01%
289
-3,547
-92% -$288K
TROX icon
665
Tronox
TROX
$888M
$25K ﹤0.01%
+1,349
New +$23.5K
RETA
666
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$24K ﹤0.01%
+238
New +$27.8K
MCK icon
667
McKesson
MCK
$100B
$22K ﹤0.01%
115
-123
-52% -$22.5K
AVTR icon
668
Avantor
AVTR
$9.78B
$21K ﹤0.01%
735
-923,563
-100% -$26.7M
IP icon
669
International Paper
IP
$22B
$21K ﹤0.01%
403
-914
-69% -$44.5K
NSTG
670
DELISTED
NanoString Technologies, Inc.
NSTG
$21K ﹤0.01%
+315
New +$22.1K
MTD icon
671
Mettler-Toledo International
MTD
$28B
$20K ﹤0.01%
17
MDLZ icon
672
Mondelez International
MDLZ
$82.3B
$19K ﹤0.01%
330
-80
-20% -$4.52K
CNI icon
673
Canadian National Railway
CNI
$78.5B
$18K ﹤0.01%
153
-1,853
-92% -$206K
IDXX icon
674
Idexx Laboratories
IDXX
$43.9B
$18K ﹤0.01%
37
-75
-67% -$37.6K
MOS icon
675
The Mosaic Company
MOS
$7.76B
$18K ﹤0.01%
575
-200
-26% -$5.9K

Similar funds

Lee Ainslie's Q1 2021 Portfolio in Review

As of Q1 2021, Lee Ainslie held 930 positions worth $10.9B, up 74% from $6.25B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Lee Ainslie deployed $4.39B of net new capital in Q1 2021, opening 269 new positions and adding to 166 existing holdings. Its largest new stake was Coupang: 110,527,590 shares worth $5.03B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 55% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $314M trimmed.

  • Lee Ainslie's largest Q1 2021 buy was Coupang: 110,527,590 shares worth $5.03B.
  • Lee Ainslie added most to Amazon in Q1 2021, an estimated $116M increase.
  • Lee Ainslie's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $314M.
  • Lee Ainslie fully exited Perspecta Inc. Common Stock in Q1 2021, selling an estimated $110M.
  • Lee Ainslie's ten largest holdings make up 65% of its $10.9B portfolio in Q1 2021.
  • Lee Ainslie opened 269 new positions and closed 242 in Q1 2021.
  • Lee Ainslie's portfolio value rose 74% quarter-over-quarter to $10.9B.

Based on Maverick Capital's 13F filing for Q1 2021, filed 17 May 2021.